3rd Quarter - Termination

WELLINGTON STRATEGIES, LLC. for OMNICELL, INC.

Period 3rd Quarter 2017 Filed Oct 18, 2017 Signed by Joseph Kuklis

Official filing
Firm
WELLINGTON STRATEGIES, LLC.
Client
OMNICELL, INC.
Income
$15,000
Expenses
—
Terminated
Sep 30, 2017

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulations pertaining to the Drug Quality and Security Act (Public Law No: 113-54)

LobbyistCovered position, as disclosed
JOSEPH KUKLIS —
LUC MONTMINY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA)

Pharmacy PHA

Regulations pertaining to the Drug Quality and Security Act (Public Law No: 113-54)

LobbyistCovered position, as disclosed
JOSEPH KUKLIS —
LUC MONTMINY —

Contacted: White House Office; Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.